Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FWEYL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,401
Award facts
- Contract value 100% obligated
- $28,400.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,400.89 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count packages). This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. Performance will take place at the contractor's Park Ridge facility.
DMS Pharmaceutical Group Inc. is executing this delivery order under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products to Department of Defense healthcare facilities worldwide. The company holds a single-award Indefinite Delivery Contract (IDC) under this program with a $499.999 billion ceiling value and completion date of December 31, 2036, structured with a 30-month base period and three 30-month option periods. This delivery order represents one of numerous purchases DMS Pharmaceutical Group has fulfilled for DLA's Medical Supply Chain division, reflecting the contractor's established performance in supplying diverse pharmaceutical products including specialty medications, biologics, vaccines, and medical consumables to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FWEYL?
SPE2DB26FWEYL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FWEYL worth?
The government has obligated $28,401 on SPE2DB26FWEYL.
Is contract SPE2DB26FWEYL an order under another contract?
Yes. SPE2DB26FWEYL is a delivery order under SPE2DB25D9320, an indefinite delivery contract.
Was contract SPE2DB26FWEYL competed?
The extent of competition for SPE2DB26FWEYL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award